The MHRA is implementing the Medical Devices (Amendment) (Great Britain) Regulations 2025 to reform how medical devices are classified, registered, and regulated in Great Britain following Brexit. The framework covers device scope, classification systems, economic operator responsibilities, data protection, and UDI requirements. Recent activity includes consultation on fetal dopplers and alignment with the Medicines and Medical Devices Act 2021.
In response to: Consultation on the future regulation of medical devices in the United Kingdom
In response to: Consultation on the future regulation of medical devices in the United Kingdom
In response to: Consultation on the future regulation of medical devices in the United Kingdom
In response to: Consultation on the future regulation of medical devices in the United Kingdom
In response to: Consultation on the future regulation of medical devices in the United Kingdom
In response to: Consultation on the future regulation of medical devices in the United Kingdom
In response to: Consultation on the future regulation of medical devices in the United Kingdom
In response to: Consultation on the future regulation of medical devices in the United Kingdom
In response to: Consultation on the future regulation of medical devices in the United Kingdom
In response to: Consultation on the future regulation of medical devices in the United Kingdom
In response to: Consultation on the future regulation of medical devices in the United Kingdom
In response to: Consultation on the future regulation of medical devices in the United Kingdom
In response to: Consultation on the future regulation of medical devices in the United Kingdom
In response to: Consultation on the future regulation of medical devices in the United Kingdom
In response to: Consultation on the future regulation of medical devices in the United Kingdom
In response to: Consultation on the future regulation of medical devices in the United Kingdom
A Bill to regulate the sale and use of fetal dopplers; and for connected purposes.
A Bill to make provision for access to innovative medical treatments; and for connected purposes. Originated in the Commons.
Third Reading 15:25:00 Bill passed.
Order of Commitment Discharged Relevant documents: 22nd and 23 rd R eports from the Delegated Powers Committee 10:06:00 Moved by Lord Saatchi: That the order of commitment be discharged. Lord Saatchi (Con): My Lords, I understand that no amendments have …
Second Reading 12:50:00 Moved by Lord Saatchi: That the Bill be now read a second time. Lord Saatchi (Con): My Lords, I beg to move that this Bill be now read a second time. These days, the parliamentarians in another …
A Bill to make provision for access to innovative medical treatments; and for connected purposes. Originated in the Commons.
First Reading 15:07:00 The Bill was brought from the Commons, read a first time and ordered to be printed.
Consideration of Bill, not amended in the Public Bill Committee New Clause 1 Action plan for an off-patent drug pathway (1) The Secretary of State shall require the Department of Health to produce an action plan for developing a pathway …
11:32:00 Debate resumed — Anne Marie Morris: I shall resume my comments on amendment 2, which would remove clause 3. The argument goes that innovation has fallen in recent years owing to the legal complexities and doctors fearing a negligence …
A Bill to make provision for access to innovative medical treatments; and for connected purposes.
A Bill to make provision for access to innovative medical treatments; and for connected purposes.
A Bill to make provision for access to innovative medical treatments; and for connected purposes.
Queen’s recommendation signified . 15:13:00 The Parliamentary Under-Secretary of State for Life Sciences (George Freeman): I beg to move, That, for the purposes of any Act resulting from the Access to Medical Treatments (Innovation) Bill, it is expedient to authorise …
Second Reading 09:48:00 Chris Heaton-Harris (Daventry) (Con): I beg to move, That the Bill be now read a Second time. Not a day goes by without those practising medicine in our national health service innovating. Talk to any doctor, and …
A Bill to make provision for access to innovative medical treatments; and for connected purposes.
A Bill to make provision for access to innovative medical treatments; and for connected purposes.